Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment.
Cacopardo
B
B
Institute of Infectious Diseases, University of Catania, Italy.
Nigro
L
L
Preiser
W
W
Famá
A
A
Satariano
M I
MI
Braner
J
J
Celesia
B M
BM
Weber
B
B
Russo
R
R
Doerr
H W
HW
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000276:immunology*; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D012367:RNA, Viral / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology*; D014779:Virus Replication
D000981:Antiprotozoal Agents; D016207:Cytokines; D009942:Organometallic Compounds; D012367:RNA, Viral; D008536:Meglumine; D000077485:Meglumine Antimoniate